anti-CD19 monoclonal antibody MDX-1342
Term · Oncology and biomedicine · MLC-T-ONC-010257
A fully human anti-CD19 monoclonal antibody directed against the B-cell-specific membrane protein CD-19 with potential antineoplastic activity. Anti-CD19 monoclonal antibody MDX-1342 binds to CD19, depleting and eliminating CD19-expressing B cells. CD19 is widely expressed during B-cell development, from pro-B-cell to early plasma cell stages.
| Identifier | MLC-T-ONC-010257 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010257",
"term": "anti-CD19 monoclonal antibody MDX-1342",
"field": "Oncology and biomedicine",
"definition": "A fully human anti-CD19 monoclonal antibody directed against the B-cell-specific membrane protein CD-19 with potential antineoplastic activity. Anti-CD19 monoclonal antibody MDX-1342 binds to CD19, depleting and eliminating CD19-expressing B cells. CD19 is widely expressed during B-cell development, from pro-B-cell to early plasma cell stages.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd19-monoclonal-antibody-mdx-1342/"
}
Record 1,343 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.